Frequency Therapeutics Stock Analysis

KRRO Stock   42.50  0.90  2.16%   
Frequency Therapeutics is undervalued with Real Value of 60.62 and Target Price of 116.67. The main objective of Frequency Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Frequency Therapeutics is worth, separate from its market price. There are two main types of Frequency Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Frequency Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Frequency Therapeutics is usually not traded on Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day. Frequency Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.

Frequency Stock Analysis Notes

About 72.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. Frequency Therapeutics had 1:50 split on the 6th of November 2023. To find out more about Frequency Therapeutics contact Ram MBA at 781-315-4600 or learn more at https://www.korrobio.com.

Frequency Therapeutics Investment Alerts

Frequency Therapeutics generated a negative expected return over the last 90 days
Frequency Therapeutics has high historical volatility and very poor performance
Frequency Therapeutics was previously known as Frequency Therapeutics and was traded on NASDAQ Exchange under the symbol FREQ.
Net Loss for the year was (81.17 M) with profit before overhead, payroll, taxes, and interest of 0.
Frequency Therapeutics generates negative cash flow from operations
Frequency Therapeutics has a frail financial position based on the latest SEC disclosures
About 72.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Lucchino David L. of 5190 shares of Frequency Therapeutics at 42.19 subject to Rule 16b-3

Frequency Therapeutics Upcoming and Recent Events

Earnings reports are used by Frequency Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
8th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Frequency Largest EPS Surprises

Earnings surprises can significantly impact Frequency Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-03-29
2020-12-31-0.254-0.3-0.04618 
2023-08-10
2023-06-30-0.36-0.30.0616 
2020-11-16
2020-09-30-0.2775-0.160.117542 
View All Earnings Estimates

Frequency Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 374.13 M.

Frequency Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.37)(0.38)
Return On Capital Employed(0.42)(0.44)
Return On Assets(0.37)(0.38)
Return On Equity(0.48)(0.45)

Technical Drivers

As of the 15th of June 2024, Frequency Therapeutics shows the Standard Deviation of 5.31, mean deviation of 3.95, and Variance of 28.2. Frequency Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Frequency Therapeutics Price Movement Analysis

null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Frequency Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Frequency Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Frequency Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Frequency Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Frequency Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Frequency Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Frequency Therapeutics Predictive Daily Indicators

Frequency Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Frequency Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Frequency Therapeutics Forecast Models

Frequency Therapeutics' time-series forecasting models are one of many Frequency Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Frequency Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Frequency Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Frequency Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Frequency shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Frequency Therapeutics. By using and applying Frequency Stock analysis, traders can create a robust methodology for identifying Frequency entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(1.79)(1.88)
Operating Profit Margin(2.90)(3.05)
Net Loss(1.80)(1.88)
Gross Profit Margin 0.65  0.56 

Current Frequency Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Frequency analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Frequency analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
116.67Buy4Odds
Frequency Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Frequency analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Frequency stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Frequency Therapeutics, talking to its executives and customers, or listening to Frequency conference calls.
Frequency Analyst Advice Details

Frequency Stock Analysis Indicators

Frequency Therapeutics stock analysis indicators help investors evaluate how Frequency Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Frequency Therapeutics shares will generate the highest return on investment. By understating and applying Frequency Therapeutics stock analysis, traders can identify Frequency Therapeutics position entry and exit signals to maximize returns.
Begin Period Cash Flow41.5 M
Common Stock Shares Outstanding1.5 M
Total Stockholder Equity169.9 M
Tax Provision27 K
Property Plant And Equipment Net42.8 M
Cash And Short Term Investments166.2 M
Cash166.2 M
Accounts Payable7.3 M
Net Debt-132.9 M
50 Day M A44.0788
Total Current Liabilities19.5 M
Other Operating Expenses84.5 M
Non Current Assets Total48.9 M
Non Currrent Assets Other2.7 M
Stock Based Compensation2.4 M

Additional Information and Resources on Investing in Frequency Stock

When determining whether Frequency Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Frequency Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Frequency Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Frequency Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.